Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Borok

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Investigative Dermatology|November 1, 1990
Effects of 13-cis retinoic acid therapy on human antibody responses to defined protein antigensN Sidell, M J Connor, B Chang, et al.
Journal of Occupational and Environmental Medicine|October 13, 2006
A projection of the impact of lipid-lowering therapy on high-risk employee disability and medical costsXue Song, Daniel M Huse, Setareh A Williams, et al.
Clinical Therapeutics|October 26, 2006
Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysisDaniel M Huse, Xue Song, Ronald J Ozminkowski, et al.
Journal of the American Geriatrics Society|May 1, 1992
The use of targeting criteria in hospitalized HMO patients: results from the demonstration phase of the Hospitalized Older Persons Evaluation (HOPE) StudyD B Reuben, G Wolde-Tsadik, B Pardamean, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 25, 2007
Effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoprotein cholesterol goals in a usual care settingMichael F Bullano, Siddhesh Kamat, Debra A Wertz, et al.
AIDS (London, England)|November 4, 2000
Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stageT B Campbell, M Borok, L Gwanzura, et al.
Pharmacotherapy|March 24, 2006
Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care settingMichael F Bullano, Debra A Wertz, Grace W Yang, et al.
Archives of Internal Medicine|April 8, 1996
Cholesterol-reduction intervention study (CRIS): a randomized trial to assess effectiveness and costs in clinical practiceG Oster, G M Borok, J Menzin, et al.
Controlled Clinical Trials|February 1, 1995
A randomized trial to assess effectiveness and cost in clinical practice: rationale and design of the Cholesterol Reduction Intervention Study (CRIS)G Oster, G M Borok, J Menzin, et al.
Annals of Epidemiology|November 1, 1995
The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment resultsL E Wagenknecht, E J Mayer, M Rewers, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Investigative Dermatology|November 1, 1990
Effects of 13-cis retinoic acid therapy on human antibody responses to defined protein antigensN Sidell, M J Connor, B Chang, et al.
Journal of Occupational and Environmental Medicine|October 13, 2006
A projection of the impact of lipid-lowering therapy on high-risk employee disability and medical costsXue Song, Daniel M Huse, Setareh A Williams, et al.
Clinical Therapeutics|October 26, 2006
Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysisDaniel M Huse, Xue Song, Ronald J Ozminkowski, et al.
Journal of the American Geriatrics Society|May 1, 1992
The use of targeting criteria in hospitalized HMO patients: results from the demonstration phase of the Hospitalized Older Persons Evaluation (HOPE) StudyD B Reuben, G Wolde-Tsadik, B Pardamean, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 25, 2007
Effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoprotein cholesterol goals in a usual care settingMichael F Bullano, Siddhesh Kamat, Debra A Wertz, et al.
AIDS (London, England)|November 4, 2000
Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stageT B Campbell, M Borok, L Gwanzura, et al.
Pharmacotherapy|March 24, 2006
Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care settingMichael F Bullano, Debra A Wertz, Grace W Yang, et al.
Archives of Internal Medicine|April 8, 1996
Cholesterol-reduction intervention study (CRIS): a randomized trial to assess effectiveness and costs in clinical practiceG Oster, G M Borok, J Menzin, et al.
Controlled Clinical Trials|February 1, 1995
A randomized trial to assess effectiveness and cost in clinical practice: rationale and design of the Cholesterol Reduction Intervention Study (CRIS)G Oster, G M Borok, J Menzin, et al.
Annals of Epidemiology|November 1, 1995
The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment resultsL E Wagenknecht, E J Mayer, M Rewers, et al.
Pageof 3